ENDOMAL

Medicine Information

Product information:

Endomal Injection contains α-β Arteether 75 mg/ml, an artemisinin derivative used in the management of malaria, particularly when injectable antimalarial therapy is clinically indicated.

Arteether acts rapidly against malaria parasites and is administered under the supervision of a qualified healthcare professional.

Key Benefits:

Arteether acts quickly against Plasmodium falciparum ensuring fast reduction of parasite load in severe malaria.
Recommended in complicated or cerebral malaria where oral therapy is not feasible.
Targets blood schizonts and interrupts parasite multiplication cycle.
Reduces fever, prevents progression to severe complications, and lowers mortality.
Safe parenteral administration with good tolerability profile.
Part of artemisinin‑based combination therapies (ACTs) recommended globally for malaria management.
Widely used in hospital settings for critically ill malaria patients.

Directions for use:

Endomal Injection should be administered only by a qualified healthcare professional. The dosage, frequency, route of administration, and duration of treatment should be determined according to the patient's age, body weight, severity of malaria, and clinical condition. Do not self-administer.

Storage and Safety Information:

Store in a cool, dry place, protected from direct sunlight.
Keep out of reach of children.
Use only under the supervision of a registered medical practitioner.
Do not self-administer.
Inform your healthcare professional about any existing medical conditions and medicines being taken.
Complete the recommended antimalarial treatment regimen as advised by the healthcare professional.
Seek immediate medical attention if severe or worsening symptoms of malaria occur.
Do not use if the ampoule or packaging is damaged or if the preparation shows visible signs of deterioration.

Medicine Information

Product information:

Key Benefits:

Directions for use:

Storage and Safety Information:

Partner with us